Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?

Loading clinical trials...

Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT? | Clinical Trials | Clareo Health

Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?

MyPEEPS LITE Trial

MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi

Prevent TB: Choice Architecture for TPT Delivery